Update of The Pioneer Project : 400 patients in the biomarker program, 58 patients in the umbrella clinical trial
Date : 31 May 2022
Category : MI Live,News,Pioneer Project
As of May 31th, 2022, 17 partner centers are recruiting patients for the biomarker component of The Pioneer Project:
Hôpital Nord/AP-HM, Hôpital Européen and Hôpital Saint Joseph (Marseille), Hôpital Larrey/Oncopôle (Toulouse), Centre Léon Bérard (Lyon), Hôpital Sainte Musse (Toulon), Centre Hospitalier d’Annecy, Centre Hospitalier Vallées de l’Ariège (Foix), Hôpital Nord-Ouest (Villefranche-sur- Saône), Centre Hospitalier Henri Duffaut (Avignon), Centre Hospitalier de Cahors, Centre Hospitalier du Pays d’Aix (Aix-en-Provence), Centre Hospitalier de Montauban, Centre Hospitalier de Bastia, Clinique Maymard (Bastia), ONCOGARD Nîmes and Alès.
Despite the difficult context of the COVID-19 pandemic, 453 patients have been screened, of which 400 have entered the biomarker component of the project (88,9% of total inclusions). In parallel, 83 patients have been screened for and 58 have entered the PIONeeR umbrella clinical trial (48,3% of total inclusions).
PIONeeR BIOMARKERS
Centre | Number of patients screened | Number of patients included |
CHU Marseille - Hopital Nord | 205 | 181 |
ONCOPOLE Toulouse | 28 | 25 |
CLB Lyon | 31 | 24 |
Bastia Maymard | 4 | 3 |
Hôpital Européen - Marseille | 12 | 12 |
Hôpital Saint Joseph - Marseille | 39 | 35 |
CH Toulon | 37 | 33 |
CH Aix Pertuis | 21 | 21 |
CH Bastia | 3 | 3 |
CH Avignon | 15 | 10 |
CHU Nimes | 15 | 13 |
ONCOGARD | 10 | 10 |
Cahors | 3 | 3 |
CHIVA | 9 | 7 |
Montauban | 3 | 3 |
Annecy | 5 | 4 |
Villefranche /S | 13 | 13 |
Total | 453 | 400 |
PIONeeR TRIAL
Centre | Number of patients screened | Number of patients included |
CHU Marseille | 58 | 39 |
CHU Toulouse | 13 | 10 |
CLC Léon Bérard | 12 | 9 |
Total | 83 | 58 |
Back